Casdin Capital is a life sciences-focused investment firm that finances the innovators and companies driving progress in the healthcare industry. The firm leverages its expertise in the sector to invest across various stages of a company's lifecycle, from early-stage ventures to public equities.

Casdin Capital

Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. 

As we push into new markets and new developments, we stick to our core principles—deep analysis, intellectual honesty, hard work and partnerships with the best people. That approach translates to thousands of conversations with the developers of the drugs, diagnostics, tools and technologies that power this industry, and the data assets and service companies that support the research and product commercialization. In our first ten years, Casdin’s hands-on approach and on-the-ground experience led us to identify the key innovations that are spurring today’s remarkable industry growth. Today, we remain just as focused. Life Sciences and Casdin Capital are just getting started.   

Oxford Nanopore Technologies

Ginkgo Bioworks

Invitae

Science 37

Nautilus Biotechnology

Sema4

23andMe

2seventy bio

Absci

NeoGenomics

Recursion Pharmaceuticals

Beam Therapeutics

Blueprint Medicines

Clover Health

Alector

SomaLogic

Codexis

Constellation Pharmaceuticals

Editas Medicine

EQRx

Exscientia

Flatiron Health

Voyager Therapeutics

Verve Therapeutics

Standard BioTools

Casdin Capital, LLC

COM:CASDINCAPITAL

Casdin Capital

Financials Not Available